| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/21/2004 | EP1408972A2 Methods for treatment of cancer with irinotecan based on mdr1 |
| 04/21/2004 | EP1408971A1 Novel quinolines and uses thereof |
| 04/21/2004 | EP1408970A1 Indolines and tetrahydro-quinolines as prodrugs for tumour treatment |
| 04/21/2004 | EP1408969A2 Use of chelators in the treatment of macular degenerative disease |
| 04/21/2004 | EP1408968A2 Receptor-adapted nicotine withdrawal by anti-cholinergic and anti-noradrenergic blockage |
| 04/21/2004 | EP1408967A2 Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents for the treatment of inflammatory and/or obstructive respiratory tract diseases |
| 04/21/2004 | EP1408966A1 A synergistic pharmaceutical combination for the prevention or treatment of diabetes |
| 04/21/2004 | EP1408965A2 Use of dual h3/m2 antagonists with a bipiperidinic structure in the treatment of cognition deficit disorders |
| 04/21/2004 | EP1408964A2 Novel use of 2- 5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts |
| 04/21/2004 | EP1408962A1 Substituted isoindoles and the use thereof |
| 04/21/2004 | EP1408961A1 2 pyrrolidone derivatives as prostanoid agonists |
| 04/21/2004 | EP1408960A1 Benz-indole and benzo-quinoline derivatives as prodrugs for tumour treatment |
| 04/21/2004 | EP1408959A1 Use of galiella lactone |
| 04/21/2004 | EP1408958A1 Benzofuranes and their use in the treatment of atrial fibrillation |
| 04/21/2004 | EP1408956A1 Uses of metal salts to stabilize taxane-based compositions |
| 04/21/2004 | EP1408955A1 Novel metallotexaphyrin derivatives |
| 04/21/2004 | EP1408954A1 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| 04/21/2004 | EP1408953A1 Carbamate compounds for use in preventing or treating bipolar disorder |
| 04/21/2004 | EP1408952A1 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 04/21/2004 | EP1408950A2 Methods of treating cytokine mediated diseases |
| 04/21/2004 | EP1408949A2 Glycine betaine and its use as anti-hemorrhagic agent |
| 04/21/2004 | EP1408948A2 Thyroid therapeutic agent |
| 04/21/2004 | EP1408947A2 Fumaric acid derivatives as nf-kappab inhibitors |
| 04/21/2004 | EP1408946A2 Histone deacetylase inhibitors |
| 04/21/2004 | EP1408945A2 Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism |
| 04/21/2004 | EP1408944A1 Erucamide compounds for the treatment and prevention to disturbances of the secretory system |
| 04/21/2004 | EP1408943A2 Pharmaceutical formulation containing an ltb4 antagonist |
| 04/21/2004 | EP1408942A1 Methods and clinical devices for the inhibition or prevention of mammalian cell growth |
| 04/21/2004 | EP1408941A2 Pharmaceutical composition and method of using the same |
| 04/21/2004 | EP1408940A2 Pharmaceutical composition comprising deramciclane for the treatment of the decline and/or damage of cognitive functions |
| 04/21/2004 | EP1408939A1 Methods for preparation and use of 1 alpha,24(s)-dihydroxyvitamin d2 |
| 04/21/2004 | EP1408938A1 Therapeutic strategies for prevention and treatment of alzheimer's disease |
| 04/21/2004 | EP1408937A2 Use of antagonists or partial agonists of 5ht1a receptors for the preparation of a medicament for treatment and prevention of gastrointestinal diseases |
| 04/21/2004 | EP1408936A2 Pharmaceutical composition |
| 04/21/2004 | EP1408934A2 Pharmaceutical composition for prophylaxis and treatment of calcium metabolism disorders comprising clodronate in combination with glyceryl palmitostearate |
| 04/21/2004 | EP1408933A2 Sildenafil citrate chewing gum formulations and methods of using the same |
| 04/21/2004 | EP1408931A1 Modifying the fatty acid composition of cell membranes of organs and tissues |
| 04/21/2004 | EP1408929A2 Ophthalmic composition containing n-acetylcysteine for the treatment of dry-eye syndrom |
| 04/21/2004 | EP1408924A1 Stabilized ascorbic acid, composition, and method of use |
| 04/21/2004 | EP1408913A2 Methods for promotion of hair growth comprising topical application of prostaglandin analogues |
| 04/21/2004 | EP1408911A1 Sustained-release therapeutic bioadhesive systems |
| 04/21/2004 | EP1408897A2 Gum resin as a carrier for topical application of pharmacologically active agents |
| 04/21/2004 | EP1408876A1 Zero-order prolonged release coaxial implants |
| 04/21/2004 | EP1408775A2 Oil compositions comprising short, medium and long chain triglycerides and use thereof in reducing weight gain |
| 04/21/2004 | EP1408757A2 Method and composition for prolonging the residence time of drugs in the gut |
| 04/21/2004 | EP1408755A1 Treatment for dry mouth employing carbamide peroxide |
| 04/21/2004 | EP1408750A2 A cream-t0-powder dermatological composition |
| 04/21/2004 | EP1320525B1 Antibacterial mutilins |
| 04/21/2004 | EP1313498A4 Phospholipase d effectors for therapy and screening |
| 04/21/2004 | EP1296946B1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof |
| 04/21/2004 | EP1287355B1 Methods and compounds for influencing beta3 integrin-dependent intracellular processes |
| 04/21/2004 | EP1272481B1 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity |
| 04/21/2004 | EP1267900B1 Emulsion containing a triterpen containing plant extract, method for producing said emulsion and for obtaining a plant extract |
| 04/21/2004 | EP1242389B1 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 04/21/2004 | EP1228039B1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 04/21/2004 | EP1204412A4 Use of etodolac to treat cancer |
| 04/21/2004 | EP1200092B1 Beta-carboline drug products |
| 04/21/2004 | EP1196381B1 Process for the preparation of n-(1,1-dimethylethyl)-4-((5'-ethoxy-4-cis-(2-(4-morpholino)ethoxy)-2'-oxospiro(cyclohexan-1,3'-(3h)indol)-1'(2'h)-yl)-sulfonyl)-3-methoxybenzamide and its salts |
| 04/21/2004 | EP1196159B1 Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 04/21/2004 | EP1187828B1 Quinoline derivatives as antibacterials |
| 04/21/2004 | EP1179184A4 Identifying material from a breast duct |
| 04/21/2004 | EP1178783B1 Device and use for increasing the transdermal permeation of medicaments |
| 04/21/2004 | EP1159004A4 Novel redox clamping agents and uses thereof |
| 04/21/2004 | EP1154987B1 Phenylalaninol derivatives |
| 04/21/2004 | EP1149094B1 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors |
| 04/21/2004 | EP1149079B1 Tetrahydro isoquino linealkanol derivatives and pharmaceutical compositions containing same |
| 04/21/2004 | EP1133496B1 Crystal modification a of 8-cyano-1- cyclopropyl -7-(1s,6s-2, 8-diazabicyclo 4.3.0]nonan -8-yl)-6- fluoro-1, 4-dihydro- 4-oxo-3- quinoline carboxylic acid |
| 04/21/2004 | EP1124546B1 Use of hyaluronic acid for the treatment of radiation cystitis |
| 04/21/2004 | EP1121099B1 Pharmaceutical composition with gastric residence and controlled release |
| 04/21/2004 | EP1113790B1 Use of a cinnamic acid derivatives for the manufacture of a medicament for preventing or treating elevated blood lipid level-related diseases |
| 04/21/2004 | EP1112074B1 Taurolidine and/or taurultam against infectious ulcer or gastritis |
| 04/21/2004 | EP1109814B1 5-heterocyclyl pyrazolo 4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction |
| 04/21/2004 | EP1105370B1 Novel aryl sulphonamides and analogues |
| 04/21/2004 | EP1071701A4 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 04/21/2004 | EP1057813B1 Indole derivatives and medicinal compositions containing the same |
| 04/21/2004 | EP1049699B1 Pyrazolotriazines as crf antagonists |
| 04/21/2004 | EP1049671B1 Azetidinecarboxamide derivatives for the treatment of cns disorders |
| 04/21/2004 | EP1039916B8 Use of at least one fucane for the manufacture of a medicament for the treatment of periodontal pathologies |
| 04/21/2004 | EP1033130B1 Inhibitor of urokinase production and of angiogenesis and its therapeutic use |
| 04/21/2004 | EP1007030B1 Solid pharmaceutical composition containing benzofurane derivatives |
| 04/21/2004 | EP0973750B1 Substituted benzimidazoles and their use for treating retroviral infection |
| 04/21/2004 | EP0964860B1 Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions |
| 04/21/2004 | EP0941095B1 Improved pharmaceutical compositions |
| 04/21/2004 | EP0939654B1 Use of no syntase inhibitors with scavengers of oxygen reactive forms for the treatment of ischemia |
| 04/21/2004 | EP0931090B1 Improved chimeric oligonucleotide vectors |
| 04/21/2004 | EP0926951B1 Treating pulmonary diseases mediated by polyunsaturated lipid metabolites and assays for epoxide hydrolase inhibitors |
| 04/21/2004 | EP0912552B1 2,4-diaminopyrimidine derivates as dopamine d4 receptor antagonists |
| 04/21/2004 | EP0909168B1 Propellant mixtures and aerosols for micronising medicaments with compressed gas |
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/21/2004 | EP0859847B1 Composition and method of imparting resistivity to hiv superinfection to cells |
| 04/21/2004 | EP0857068B1 Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes |
| 04/21/2004 | EP0856007B1 Cyclopeptide derivatives |
| 04/21/2004 | EP0839024B1 Monensin formulations |
| 04/21/2004 | EP0815218B1 Human vegf-specific antisense oligonucleotides |
| 04/21/2004 | EP0799043B1 Cyclophasic hormonal regimen containing antiprogestin and progestin |
| 04/21/2004 | EP0774962B1 Use of dha in the treatment of dyslexia |
| 04/21/2004 | EP0683781B1 Novel inhibitors of adenosine monophosphate deaminase |
| 04/21/2004 | CN2612670Y Apparatus for preparing anticoagulant cellulose sulfate pharmaceutical |
| 04/21/2004 | CN1491284A Process for preparation of one or more statins by fermentation |
| 04/21/2004 | CN1491230A Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |